Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

doi:10.1084/jem.179.3.921

3rd Skeletal Biology and Medicine Symposium

This Article

Full Text (PDF)

Alert me when this article is cited

Citation Map

Services

Email this article

Similar articles in this journal

Similar articles in PubMed

Alert me to new content in the JEM

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via CrossRef

Citing Articles via Google Scholar

Google Scholar

Articles by Gaugler, B.

Articles by Boon, T.

Search for Related Content

PubMed

PubMed Citation

Articles by Gaugler, B.

Articles by Boon, T.

Pubmed/NCBI databases

Medline Plus Health Information
Gene	GEO Profiles
HomoloGene	Nucleotide
Protein	UniGene
Substance via MeSH
Melanoma

Social Bookmarking

What's this?

ARTICLES

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

B Gaugler, B Van den Eynde, P van der Bruggen, P Romero, JJ Gaforio, E De Plaen, B Lethe, F Brasseur and T Boon
Ludwig Institute for Cancer Research, Brussels Branch, Switzerland.

Human melanoma cell line MZ2-MEL expresses several antigens recognized by autologous cytolytic T lymphocyte (CTL) clones. We reported previously the identification of a gene, named MAGE-1, that codes for one of these antigens named MZ2-E. We show here that antigen MZ2-D, which is present on the same tumor, is encoded by another member of the MAGE gene family named MAGE-3. Like MAGE-1, MAGE-3 is composed of three exons and the large open reading frame is entirely located in the third exon. Its sequence shows 73% identity with MAGE-1. Like MZ2-E, antigen MZ2-D is presented by HLA-A1. The antigenic peptide of MZ2-D is a nonapeptide that is encoded by the sequence of MAGE-3 that is homologous to the MAGE-1 sequence coding for the MZ2-E peptide. Competition experiments using single Ala-substituted peptides indicated that amino acid residues Asp in position 3 and Tyr in position 9 were essential for binding of the MAGE-1 peptide to HLA-A1. Gene MAGE-3 is expressed in many tumors of several types, such as melanoma, head and neck squamous cell carcinoma, lung carcinoma and breast carcinoma, but not in normal tissues except for testes. It is expressed in a larger proportion of melanoma samples than MAGE-1. MAGE-3 encoded antigens may therefore have a wide applicability for specific immunotherapy of melanoma patients.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Liu, W., Cheng, S., Asa, S. L., Ezzat, S. (2008). The Melanoma-Associated Antigen A3 Mediates Fibronectin-Controlled Cancer Progression and Metastasis. Cancer Res. 68: 8104-8112 [Abstract] [Full Text]
Connerotte, T., Van Pel, A., Godelaine, D., Tartour, E., Schuler-Thurner, B., Lucas, S., Thielemans, K., Schuler, G., Coulie, P. G. (2008). Functions of Anti-MAGE T-Cells Induced in Melanoma Patients under Different Vaccination Modalities. Cancer Res. 68: 3931-3940 [Abstract] [Full Text]
Marturano, J., Longhi, R., Russo, V., Protti, M. P. (2008). Endosomal Proteases Influence the Repertoire of MAGE-A3 Epitopes Recognized In vivo by CD4+ T Cells. Cancer Res. 68: 1555-1562 [Abstract] [Full Text]
Carrasco, J., Van Pel, A., Neyns, B., Lethe, B., Brasseur, F., Renkvist, N., van der Bruggen, P., van Baren, N., Paulus, R., Thielemans, K., Boon, T., Godelaine, D. (2008). Vaccination of a Melanoma Patient with Mature Dendritic Cells Pulsed with MAGE-3 Peptides Triggers the Activity of Nonvaccine Anti-Tumor Cells. J. Immunol. 180: 3585-3593 [Abstract] [Full Text]
Slingluff, C. L. Jr., Petroni, G. R., Chianese-Bullock, K. A., Smolkin, M. E., Hibbitts, S., Murphy, C., Johansen, N., Grosh, W. W., Yamshchikov, G. V., Neese, P. Y., Patterson, J. W., Fink, R., Rehm, P. K. (2007). Immunologic and Clinical Outcomes of a Randomized Phase II Trial of Two Multipeptide Vaccines for Melanoma in the Adjuvant Setting. Clin. Cancer Res. 13: 6386-6395 [Abstract] [Full Text]
Naslund, T. I., Uyttenhove, C., Nordstrom, E. K. L., Colau, D., Warnier, G., Jondal, M., Van den Eynde, B. J., Liljestrom, P. (2007). Comparative Prime-Boost Vaccinations Using Semliki Forest Virus, Adenovirus, and ALVAC Vectors Demonstrate Differences in the Generation of a Protective Central Memory CTL Response against the P815 Tumor. J. Immunol. 178: 6761-6769 [Abstract] [Full Text]
Condomines, M., Hose, D., Raynaud, P., Hundemer, M., De Vos, J., Baudard, M., Moehler, T., Pantesco, V., Moos, M., Schved, J.-F., Rossi, J.-F., Reme, T., Goldschmidt, H., Klein, B. (2007). Cancer/Testis Genes in Multiple Myeloma: Expression Patterns and Prognosis Value Determined by Microarray Analysis. J. Immunol. 178: 3307-3315 [Abstract] [Full Text]
Hodi, F. S. (2006). Well-Defined Melanoma Antigens as Progression Markers for Melanoma: Insights into Differential Expression and Host Response Based on Stage. Clin. Cancer Res. 12: 673-678 [Full Text]
van Baren, N., Bonnet, M.-C., Dreno, B., Khammari, A., Dorval, T., Piperno-Neumann, S., Lienard, D., Speiser, D., Marchand, M., Brichard, V. G., Escudier, B., Negrier, S., Dietrich, P.-Y., Maraninchi, D., Osanto, S., Meyer, R. G., Ritter, G., Moingeon, P., Tartaglia, J., van der Bruggen, P., Coulie, P. G., Boon, T. (2005). Tumoral and Immunologic Response After Vaccination of Melanoma Patients With an ALVAC Virus Encoding MAGE Antigens Recognized by T Cells. JCO 23: 9008-9021 [Abstract] [Full Text]
Luiten, R. M., Kueter, E. W.M., Mooi, W., Gallee, M. P.W., Rankin, E. M., Gerritsen, W. R., Clift, S. M., Nooijen, W. J., Weder, P., van de Kasteele, W. F., Sein, J., van den Berk, P. C.M., Nieweg, O. E., Berns, A. M., Spits, H., de Gast, G. C. (2005). Immunogenicity, Including Vitiligo, and Feasibility of Vaccination With Autologous GM-CSF-Transduced Tumor Cells in Metastatic Melanoma Patients. JCO 23: 8978-8991 [Abstract] [Full Text]
Nagata, Y., Hanagiri, T., Takenoyama, M., Fukuyama, T., Mizukami, M., So, T., Ichiki, Y., Sugaya, M., Sugio, K., Yasumoto, K. (2005). Identification of the HLA-Cw*0702-Restricted Tumor-Associated Antigen Recognized by a CTL Clone from a Lung Cancer Patient. Clin. Cancer Res. 11: 5265-5272 [Abstract] [Full Text]
Koyanagi, K., Kuo, C., Nakagawa, T., Mori, T., Ueno, H., Lorico, A. R. Jr, Wang, H.-J., Hseuh, E., O'Day, S. J., Hoon, D. S.B. (2005). Multimarker Quantitative Real-Time PCR Detection of Circulating Melanoma Cells in Peripheral Blood: Relation to Disease Stage in Melanoma Patients. Clin. Chem. 51: 981-988 [Abstract] [Full Text]
Dieckmann, D., Schultz, E. S., Ring, B., Chames, P., Held, G., Hoogenboom, H. R., Schuler, G. (2005). Optimizing the exogenous antigen loading of monocyte-derived dendritic cells. Int Immunol 17: 621-635 [Abstract] [Full Text]
Zhang, Y., Sun, Z., Nicolay, H., Meyer, R. G., Renkvist, N., Stroobant, V., Corthals, J., Carrasco, J., Eggermont, A. M. M., Marchand, M., Thielemans, K., Wolfel, T., Boon, T., van der Bruggen, P. (2005). Monitoring of Anti-Vaccine CD4 T Cell Frequencies in Melanoma Patients Vaccinated with a MAGE-3 Protein. J. Immunol. 174: 2404-2411 [Abstract] [Full Text]
van Dinten, L. C., Pul, N., van Nieuwpoort, A. F., Out, C. J., Jager, M. J., van den Elsen, P. J. (2005). Uveal and Cutaneous Melanoma: Shared Expression Characteristics of Melanoma-Associated Antigens. IOVS 46: 24-30 [Abstract] [Full Text]
Wong, R., Lau, R., Chang, J., Kuus-Reichel, T., Brichard, V., Bruck, C., Weber, J. (2004). Immune Responses to a Class II Helper Peptide Epitope in Patients with Stage III/IV Resected Melanoma. Clin. Cancer Res. 10: 5004-5013 [Abstract] [Full Text]
Takeuchi, H., Morton, D. L., Kuo, C., Turner, R. R., Elashoff, D., Elashoff, R., Taback, B., Fujimoto, A., Hoon, D. S.B. (2004). Prognostic Significance of Molecular Upstaging of Paraffin-Embedded Sentinel Lymph Nodes in Melanoma Patients. JCO 22: 2671-2680 [Abstract] [Full Text]
Bonehill, A., Heirman, C., Tuyaerts, S., Michiels, A., Breckpot, K., Brasseur, F., Zhang, Y., van der Bruggen, P., Thielemans, K. (2004). Messenger RNA-Electroporated Dendritic Cells Presenting MAGE-A3 Simultaneously in HLA Class I and Class II Molecules. J. Immunol. 172: 6649-6657 [Abstract] [Full Text]
Yang, S., Haluska, F. G. (2004). Treatment of Melanoma with 5-Fluorouracil or Dacarbazine In Vitro Sensitizes Cells to Antigen-Specific CTL Lysis through Perforin/Granzyme- and Fas-Mediated Pathways. J. Immunol. 172: 4599-4608 [Abstract] [Full Text]
Atanackovic, D., Altorki, N. K., Stockert, E., Williamson, B., Jungbluth, A. A., Ritter, E., Santiago, D., Ferrara, C. A., Matsuo, M., Selvakumar, A., Dupont, B., Chen, Y.-T., Hoffman, E. W., Ritter, G., Old, L. J., Gnjatic, S. (2004). Vaccine-Induced CD4+ T Cell Responses to MAGE-3 Protein in Lung Cancer Patients. J. Immunol. 172: 3289-3296 [Abstract] [Full Text]
Breckpot, K., Heirman, C., De Greef, C., van der Bruggen, P., Thielemans, K. (2004). Identification of New Antigenic Peptide Presented by HLA-Cw7 and Encoded by Several MAGE Genes Using Dendritic Cells Transduced with Lentiviruses. J. Immunol. 172: 2232-2237 [Abstract] [Full Text]
Sienel, W., Varwerk, C., Linder, A., Kaiser, D., Teschner, M., Delire, M., Stamatis, G., Passlick, B. (2004). Melanoma associated antigen (MAGE)-A3 expression in Stages I and II non-small cell lung cancer: results of a multi-center study. Eur. J. Cardiothorac. Surg. 25: 131-134 [Abstract] [Full Text]
Godelaine, D., Carrasco, J., Lucas, S., Karanikas, V., Schuler-Thurner, B., Coulie, P. G., Schuler, G., Boon, T., Van Pel, A. (2003). Polyclonal CTL Responses Observed in Melanoma Patients Vaccinated with Dendritic Cells Pulsed with a MAGE-3.A1 Peptide. J. Immunol. 171: 4893-4897 [Abstract] [Full Text]
Nagorsen, D., Scheibenbogen, C., Marincola, F. M., Letsch, A., Keilholz, U. (2003). Natural T Cell Immunity against Cancer. Clin. Cancer Res. 9: 4296-4303 [Abstract] [Full Text]
Astsaturov, I., Petrella, T., Bagriacik, E. U., de Benedette, M., Uger, R., Lumber, G., Berinstein, N., Elias, I., Iscoe, N., Hammond, C., Hamilton, P., Spaner, D. E. (2003). Amplification of Virus-Induced Antimelanoma T-Cell Reactivity by High-Dose Interferon-{alpha}2b: Implications for Cancer Vaccines. Clin. Cancer Res. 9: 4347-4355 [Abstract] [Full Text]
Matsui, K., O'Mara, L. A., Allen, P. M. (2003). Successful elimination of large established tumors and avoidance of antigen-loss variants by aggressive adoptive T cell immunotherapy. Int Immunol 15: 797-805 [Abstract] [Full Text]
Lee, S.-Y., Obata, Y., Yoshida, M., Stockert, E., Williamson, B., Jungbluth, A. A., Chen, Y.-T., Old, L. J., Scanlan, M. J. (2003). Immunomic analysis of human sarcoma. Proc. Natl. Acad. Sci. USA 100: 2651-2656 [Abstract] [Full Text]
Reynolds, S. R., Zeleniuch-Jacquotte, A., Shapiro, R. L., Roses, D. F., Harris, M. N., Johnston, D., Bystryn, J.-C. (2003). Vaccine-induced CD8+ T-cell Responses to MAGE-3 Correlate with Clinical Outcome in Patients with Melanoma. Clin. Cancer Res. 9: 657-662 [Abstract] [Full Text]
Koslowski, M., Tureci, O., Bell, C., Krause, P., Lehr, H.-A., Brunner, J., Seitz, G., Nestle, F. O., Huber, C., Sahin, U. (2002). Multiple Splice Variants of Lactate Dehydrogenase C Selectively Expressed in Human Cancer ,. Cancer Res. 62: 6750-6755 [Abstract] [Full Text]
Scanlan, M. J., Welt, S., Gordon, C. M., Chen, Y.-T., Gure, A. O., Stockert, E., Jungbluth, A. A., Ritter, G., Jager, D., Jager, E., Knuth, A., Old, L. J. (2002). Cancer-related Serological Recognition of Human Colon Cancer: Identification of Potential Diagnostic and Immunotherapeutic Targets. Cancer Res. 62: 4041-4047 [Abstract] [Full Text]
Sosman, J. A., Unger, J. M., Liu, P.-Y., Flaherty, L. E., Park, M. S., Kempf, R. A., Thompson, J. A., Terasaki, P. I., Sondak, V. K. (2002). Adjuvant Immunotherapy of Resected, Intermediate-Thickness, Node-Negative Melanoma With an Allogeneic Tumor Vaccine: Impact of HLA Class I Antigen Expression on Outcome. JCO 20: 2067-2075 [Abstract] [Full Text]
Kufer, P., Zippelius, A., Lutterbuse, R., Mecklenburg, I., Enzmann, T., Montag, A., Weckermann, D., Passlick, B., Prang, N., Reichardt, P., Dugas, M., Kollermann, M. W., Pantel, K., Riethmuller, G. (2002). Heterogeneous Expression of MAGE-A Genes in Occult Disseminated Tumor Cells: A Novel Multimarker Reverse Transcription-Polymerase Chain Reaction for Diagnosis of Micrometastatic Disease. Cancer Res. 62: 251-261 [Abstract] [Full Text]
Zammatteo, N., Lockman, L., Brasseur, F., De Plaen, E., Lurquin, C., Lobert, P.-E., Hamels, S., Boon, T., Remacle, J. (2002). DNA Microarray to Monitor the Expression of MAGE-A Genes. Clin. Chem. 48: 25-34 [Abstract] [Full Text]
Smith, S. G., Patel, P. M., Porte, J., Selby, P. J., Jackson, A. M. (2001). Human Dendritic Cells Genetically Engineered to Express a Melanoma Polyepitope DNA Vaccine Induce Multiple Cytotoxic T-Cell Responses. Clin. Cancer Res. 7: 4253-4261 [Abstract] [Full Text]
Kao, H., Marto, J. A., Hoffmann, T. K., Shabanowitz, J., Finkelstein, S. D., Whiteside, T. L., Hunt, D. F., Finn, O. J. (2001). Identification of Cyclin B1 as a Shared Human Epithelial Tumor-Associated Antigen Recognized by T Cells. J. Exp. Med. 194: 1313-1324 [Abstract] [Full Text]
Sato, K., Torimoto, Y., Tamura, Y., Shindo, M., Shinzaki, H., Hirai, K., Kohgo, Y. (2001). Immunotherapy using heat-shock protein preparations of leukemia cells after syngeneic bone marrow transplantation in mice. Blood 98: 1852-1857 [Abstract] [Full Text]
Jager, D, Jager, E, Knuth, A (2001). Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer. J. Clin. Pathol. 54: 669-674 [Abstract] [Full Text]
Coulie, P. G., Karanikas, V., Colau, D., Lurquin, C., Landry, C., Marchand, M., Dorval, T., Brichard, V., Boon, T. (2001). A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3. Proc. Natl. Acad. Sci. USA 10.1073/pnas.161260098v1 [Abstract] [Full Text]
Sadanaga, N., Nagashima, H., Mashino, K., Tahara, K., Yamaguchi, H., Ohta, M., Fujie, T., Tanaka, F., Inoue, H., Takesako, K., Akiyoshi, T., Mori, M. (2001). Dendritic Cell Vaccination with MAGE Peptide Is A Novel Therapeutic Approach for Gastrointestinal Carcinomas. Clin. Cancer Res. 7: 2277-2284 [Abstract] [Full Text]
Meyer zum Buschenfelde, C., Metzger, J., Hermann, C., Nicklisch, N., Peschel, C., Bernhard, H. (2001). The Generation of Both T Killer and Th Cell Clones Specific for the Tumor-Associated Antigen HER2 Using Retrovirally Transduced Dendritic Cells. J. Immunol. 167: 1712-1719 [Abstract] [Full Text]
Gricks, C. S., Rawlings, E., Foroni, L., Madrigal, J. A., Amlot, P. L. (2001). Somatically Mutated Regions of Immunoglobulin on Human B-Cell Lymphomas Code for Peptides That Bind to Autologous Major Histocompatibility Complex Class I, Providing a Potential Target for Cytotoxic T Cells. Cancer Res. 61: 5145-5152 [Abstract] [Full Text]
Kobayashi, H., Song, Y., Hoon, D. S. B., Appella, E., Celis, E. (2001). Tumor-reactive T Helper Lymphocytes Recognize a Promiscuous MAGE-A3 Epitope Presented by Various Major Histocompatibility Complex Class II Alleles. Cancer Res. 61: 4773-4778 [Abstract] [Full Text]
Sherritt, M., Cooper, L., Moss, D. J., Kienzle, N., Altman, J., Khanna, R. (2001). Immunization with tumor-associated epitopes fused to an endoplasmic reticulum translocation signal sequence affords protection against tumors with down-regulated expression of MHC and peptide transporters. Int Immunol 13: 265-271 [Abstract] [Full Text]
Ito, M., Shichijo, S., Tsuda, N., Ochi, M., Harashima, N., Saito, N., Itoh, K. (2001). Molecular Basis of T Cell-mediated Recognition of Pancreatic Cancer Cells. Cancer Res. 61: 2038-2046 [Abstract] [Full Text]
Frost, P. J., Butterfield, L. H., Dissette, V. B., Economou, J. S., Bonavida, B. (2001). Immunosensitization of Melanoma Tumor Cells to Non-MHC Fas-Mediated Killing by MART-1-Specific CTL Cultures. J. Immunol. 166: 3564-3573 [Abstract] [Full Text]
Weiser, T. S., Ohnmacht, G. A., Guo, Z. S., Fischette, M. R., Chen, G. A., Hong, J. A., Nguyen, D. M., Schrump, D. S. (2001). Induction of MAGE-3 expression in lung and esophageal cancer cells. Ann. Thorac. Surg. 71: 295-302 [Abstract] [Full Text]
You, Z., Hester, J., Rollins, L., Spagnoli, G. C., van der Bruggen, P., Chen, S.-Y. (2001). A Retrogen Strategy for Presentation of an Intracellular Tumor Antigen as an Exogenous Antigen by Dendritic Cells Induces Potent Antitumor T Helper and CTL Responses. Cancer Res. 61: 197-205 [Abstract] [Full Text]
Valmori, D., Dutoit, V., Rubio-Godoy, V., Chambaz, C., Liénard, D., Guillaume, P., Romero, P., Cerottini, J.-C., Rimoldi, D. (2001). Frequent Cytolytic T-Cell Responses to Peptide MAGE-A10254-262 in Melanoma. Cancer Res. 61: 509-512 [Abstract] [Full Text]
Nishiyama, T., Tachibana, M., Horiguchi, Y., Nakamura, K., Ikeda, Y., Takesako, K., Murai, M. (2001). Immunotherapy of Bladder Cancer Using Autologous Dendritic Cells Pulsed with Human Lymphocyte Antigen-A24-specific MAGE-3 Peptide. Clin. Cancer Res. 7: 23-31 [Abstract] [Full Text]
Shaif-Muthana, M., McIntyre, C., Sisley, K., Rennie, I., Murray, A. (2000). Dead or Alive: Immunogenicity of Human Melanoma Cells When Presented by Dendritic Cells. Cancer Res. 60: 6441-6447 [Abstract] [Full Text]
Jäger, E., Gnjatic, S., Nagata, Y., Stockert, E., Jäger, D., Karbach, J., Neumann, A., Rieckenberg, J., Chen, Y.-T., Ritter, G., Hoffman, E., Arand, M., Old, L. J., Knuth, A. (2000). Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proc. Natl. Acad. Sci. USA 10.1073/pnas.220413497v1 [Abstract] [Full Text]
Heidecker, L., Brasseur, F., Probst-Kepper, M., Gueguen, M., Boon, T., Van den Eynde, B. J. (2000). Cytolytic T Lymphocytes Raised Against a Human Bladder Carcinoma Recognize an Antigen Encoded by Gene MAGE-A12. J. Immunol. 164: 6041-6045 [Abstract] [Full Text]
Oka, Y., Udaka, K., Tsuboi, A., Elisseeva, O. A., Ogawa, H., Aozasa, K., Kishimoto, T., Sugiyama, H. (2000). Cancer Immunotherapy Targeting Wilms' Tumor Gene WT1 Product. J. Immunol. 164: 1873-1880 [Abstract] [Full Text]
Thurner, B., Haendle, I., Roder, C., Dieckmann, D., Keikavoussi, P., Jonuleit, H., Bender, A., Maczek, C., Schreiner, D., von den Driesch, P., Brocker, E. B., Steinman, R. M., Enk, A., Kampgen, E., Schuler, G. (1999). Vaccination with Mage-3A1 Peptide-pulsed Mature, Monocyte-derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma. J. Exp. Med. 190: 1669-1678 [Abstract] [Full Text]
Jager, D., Stockert, E., Scanlan, M. J., Gure, A. O., Jager, E., Knuth, A., Old, L. J., Chen, Y.-T. (1999). Cancer-Testis Antigens and ING1 Tumor Suppressor Gene Product Are Breast Cancer Antigens: Characterization of Tissue-specific ING1 Transcripts and a Homologue Gene. Cancer Res. 59: 6197-6204 [Abstract] [Full Text]
Chiari, R., Foury, F., De Plaen, E., Baurain, J.-F., Thonnard, J., G. Coulie, P. (1999). Two Antigens Recognized by Autologous Cytolytic T Lymphocytes on a Melanoma Result from a Single Point Mutation in an Essential Housekeeping Gene. Cancer Res. 59: 5785-5792 [Abstract] [Full Text]
Wang, F., Bade, E., Kuniyoshi, C., Spears, L., Jeffery, G., Marty, V., Groshen, S., Weber, J. (1999). Phase I Trial of a MART-1 Peptide Vaccine with Incomplete Freund's Adjuvant for Resected High-Risk Melanoma. Clin. Cancer Res. 5: 2756-2765 [Abstract] [Full Text]
Yamazaki, K., Spruill, G., Rhoderick, J., Spielman, J., Savaraj, N., Podack, E. R. (1999). Small Cell Lung Carcinomas Express Shared and Private Tumor Antigens Presented by HLA-A1 or HLA-A2. Cancer Res. 59: 4642-4650 [Abstract] [Full Text]
Suzuki, K., Sahara, H., Okada, Y., Yasoshima, T., Hirohashi, Y., Nabeta, Y., Hirai, I., Torigoe, T., Takahashi, S., Matsuura, A., Takahashi, N., Sasaki, A., Suzuki, M., Hamuro, J., Ikeda, H., Wada, Y., Hirata, K., Kikuchi, K., Sato, N. (1999). Identification of Natural Antigenic Peptides of a Human Gastric Signet Ring Cell Carcinoma Recognized by HLA-A31-Restricted Cytotoxic T Lymphocytes. J. Immunol. 163: 2783-2791 [Abstract] [Full Text]
Chaux, P., Luiten, R., Demotte, N., Vantomme, V., Stroobant, V., Traversari, C., Russo, V., Schultz, E., Cornelis, G. R., Boon, T., van der Bruggen, P. (1999). Identification of Five MAGE-A1 Epitopes Recognized by Cytolytic T Lymphocytes Obtained by In Vitro Stimulation with Dendritic Cells Transduced with MAGE-A1. J. Immunol. 163: 2928-2936 [Abstract] [Full Text]
Yang, D., Nakao, M., Shichijo, S., Sasatomi, T., Takasu, H., Matsumoto, H., Mori, K., Hayashi, A., Yamana, H., Shirouzu, K., Itoh, K. (1999). Identification of a Gene Coding for a Protein Possessing Shared Tumor Epitopes Capable of Inducing HLA-A24-restricted Cytotoxic T Lymphocytes inCancer Patients. Cancer Res. 59: 4056-4063 [Abstract] [Full Text]
Tahara, K., Takesako, K., Sette, A., Celis, E., Kitano, S., Akiyoshi, T. (1999). Identification of a MAGE-2-encoded Human Leukocyte Antigen-A24-binding Synthetic Peptide That Induces Specific Antitumor Cytotoxic T Lymphocytes. Clin. Cancer Res. 5: 2236-2241 [Abstract] [Full Text]
Ronsin, C., Chung-Scott, V., Poullion, I., Aknouche, N., Gaudin, C., Triebel, F. (1999). A Non-AUG-Defined Alternative Open Reading Frame of the Intestinal Carboxyl Esterase mRNA Generates an Epitope Recognized by Renal Cell Carcinoma-Reactive Tumor-Infiltrating Lymphocytes In Situ. J. Immunol. 163: 483-490 [Abstract] [Full Text]
Evans, T.R.J., Kaye, S.B. (1999). Vaccine therapy for cancer�fact or fiction?. QJM 92: 299-307 [Full Text]
Tanzarella, S., Russo, V., Lionello, I., Dalerba, P., Rigatti, D., Bordignon, C., Traversari, C. (1999). Identification of a Promiscuous T-Cell Epitope Encoded by Multiple Members of the MAGE Family. Cancer Res. 59: 2668-2674 [Abstract] [Full Text]
Huang, L.-Q., Brasseur, F., Serrano, A., De Plaen, E., van der Bruggen, P., Boon, T., Van Pel, A. (1999). Cytolytic T Lymphocytes Recognize an Antigen Encoded by MAGE-A10 on a Human Melanoma. J. Immunol. 162: 6849-6854 [Abstract] [Full Text]
Rohrer, J. W., Barsoum, A. L., Dyess, D. L., Tucker, J. A., Coggin, J. H. Jr. (1999). Human Breast Carcinoma Patients Develop Clonable Oncofetal Antigen-Specific Effector and Regulatory T Lymphocytes. J. Immunol. 162: 6880-6892 [Abstract] [Full Text]
Imro, M. A., Manici, S., Russo, V., Consogno, G., Bellone, M., Rugarli, C., Traversari, C., Protti, M. P. (1999). Major Histocompatibility Complex Class I Restricted Cytotoxic T Cells Specific for Natural Melanoma Peptides Recognize Unidentified Shared Melanoma Antigen(s). Cancer Res. 59: 2287-2291 [Abstract] [Full Text]
Maitre, N., Brown, J. M., Demcheva, M., Kelley, J. R., Lockett, M. A., Vournakis, J., Cole, D. J. (1999). Primary T-Cell and Activated Macrophage Response Associated with Tumor Protection Using Peptide/Poly-N-Acetyl Glucosamine Vaccination. Clin. Cancer Res. 5: 1173-1182 [Abstract] [Full Text]
Ayyoub, M., Mazarguil, H., Monsarrat, B., Van den Eynde, B., Gairin, J. E. (1999). A Structure-based Approach to Designing Non-natural Peptides That Can Activate Anti-melanoma Cytotoxic T Cells. J. Biol. Chem. 274: 10227-10234 [Abstract] [Full Text]
Valmori, D., Gileadi, U., Servis, C., Dunbar, P. R., Cerottini, J.-C., Romero, P., Cerundolo, V., Levy, F. (1999). Modulation of Proteasomal Activity Required for the Generation of a Cytotoxic T Lymphocyte-defined Peptide Derived from the Tumor Antigen MAGE-3. J. Exp. Med. 189: 895-906 [Abstract] [Full Text]
Bilsborough, J., Van Pel, A., Uyttenhove, C., Boon, T., Van den Eynde, B. J. (1999). Identification of a Second Major Tumor-Specific Antigen Recognized by CTLs on Mouse Mastocytoma P815. J. Immunol. 162: 3534-3540 [Abstract] [Full Text]
Chaux, P., Vantomme, V., Stroobant, V., Thielemans, K., Corthals, J., Luiten, R., Eggermont, A. M.M., Boon, T., van der Bruggen, P. (1999). Identification of MAGE-3 Epitopes Presented by HLA-DR Molecules to CD4+ T Lymphocytes. J. Exp. Med. 189: 767-778 [Abstract] [Full Text]
Sarma, S., Guo, Y., Guilloux, Y., Lee, C., Bai, X.-F., Liu, Y. (1999). Cytotoxic T Lymphocytes to An Unmutated Tumor Rejection Antigen P1A: Normal Development but Restrained Effector Function In Vivo. J. Exp. Med. 189: 811-820 [Abstract] [Full Text]
Scarcella, D. L., Chow, C. W., Gonzales, M. F., Economou, C., Brasseur, F., Ashley, D. M. (1999). Expression of MAGE and GAGE in High-Grade Brain Tumors: A Potential Target for Specific Immunotherapy and Diagnostic Markers. Clin. Cancer Res. 5: 335-341 [Abstract] [Full Text]
Castelli, C., Tarsini, P., Mazzocchi, A., Rini, F., Rivoltini, L., Ravagnani, F., Gallino, F., Belli, F., Parmiani, G. (1999). Novel HLA-Cw8-Restricted T Cell Epitopes Derived from Tyrosinase-Related Protein-2 and gp100 Melanoma Antigens. J. Immunol. 162: 1739-1748 [Abstract] [Full Text]
Palmieri, G., Strazzullo, M., Ascierto, P. A., Satriano, S. M.R., Daponte, A., Castello, G. (1999). Polymerase Chain Reaction-Based Detection of Circulating Melanoma Cells as an Effective Marker of Tumor Progression. JCO 17: 304-304 [Abstract] [Full Text]
Dalmau, J., Gultekin, S. H., Voltz, R., Hoard, R., DesChamps, T., Balmaceda, C., Batchelor, T., Gerstner, E., Eichen, J., Frennier, J., Posner, J. B., Rosenfeld, M. R. (1999). Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain 122: 27-39 [Abstract] [Full Text]
Kuhne, C., Banks, L. (1998). E3-Ubiquitin Ligase/E6-AP Links Multicopy Maintenance Protein 7�to the Ubiquitination Pathway by a Novel Motif, the L2G Box. J. Biol. Chem. 273: 34302-34309 [Abstract] [Full Text]
Reynolds, S. R., Celis, E., Sette, A., Oratz, R., Shapiro, R. L., Johnston, D., Fotino, M., Bystryn, J.-C. (1998). HLA-Independent Heterogeneity of CD8+ T Cell Responses to MAGE-3, Melan-A/MART-1, gp100, Tyrosinase, MC1R, and TRP-2 in Vaccine-Treated Melanoma Patients. J. Immunol. 161: 6970-6976 [Abstract] [Full Text]
Wang, R.-F., Johnston, S. L., Zeng, G., Topalian, S. L., Schwartzentruber, D. J., Rosenberg, S. A. (1998). A Breast and Melanoma-Shared Tumor Antigen: T Cell Responses to Antigenic Peptides Translated from Different Open Reading Frames. J. Immunol. 161: 3596-3606 [Abstract] [Full Text]
Bettinotti, M. P., Kim, C. J., Lee, K.-H., Roden, M., Cormier, J. N., Panelli, M., Parker, K. K., Marincola, F. M. (1998). Stringent Allele/Epitope Requirements for MART-1/Melan A Immunodominance: Implications for Peptide-Based Immunotherapy. J. Immunol. 161: 877-889 [Abstract] [Full Text]
Bohm, W., Thoma, S., Leithauser, F., Moller, P., Schirmbeck, R., Reimann, J. (1998). T Cell-Mediated, IFN-{gamma}-Facilitated Rejection of Murine B16 Melanomas. J. Immunol. 161: 897-908 [Abstract] [Full Text]
Chen, M. E., Lin, S.-H., Chung, L. W.�K., Sikes, R. A. (1998). Isolation and Characterization of PAGE-1 and GAGE-7. NEW GENES EXPRESSED IN THE LNCaP PROSTATE CANCER PROGRESSION MODEL THAT SHARE HOMOLOGY WITH MELANOMA-ASSOCIATED ANTIGENS. J. Biol. Chem. 273: 17618-17625 [Abstract] [Full Text]
Gueguen, M., Patard, J.-J., Gaugler, B., Brasseur, F., Renauld, J.-C., Van Cangh, P. J., Boon, T., Van den Eynde, B. J. (1998). An Antigen Recognized by Autologous CTLs on a Human Bladder Carcinoma. J. Immunol. 160: 6188-6194 [Abstract] [Full Text]
Chen, Y.-T., Gure, A. O., Tsang, S., Stockert, E., Jager, E., Knuth, A., Old, L. J. (1998). Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc. Natl. Acad. Sci. USA 95: 6919-6923 [Abstract] [Full Text]
Kittlesen, D. J., Thompson, L. W., Gulden, P. H., Skipper, J. C. A., Colella, T. A., Shabanowitz, J. A., Hunt, D. F., Engelhard, V. H., Slingluff, C. L. Jr. (1998). Human Melanoma Patients Recognize an HLA-A1-Restricted CTL Epitope from Tyrosinase Containing Two Cysteine Residues: Implications for Tumor Vaccine Development. J. Immunol. 160: 2099-2106 [Abstract] [Full Text]
Shichijo, S., Nakao, M., Imai, Y., Takasu, H., Kawamoto, M., Niiya, F., Yang, D., Toh, Y., Yamana, H., Itoh, K. (1998). A Gene Encoding Antigenic Peptides of Human Squamous Cell Carcinoma Recognized by Cytotoxic T Lymphocytes. J. Exp. Med. 187: 277-288 [Abstract] [Full Text]
Tuting, T., Wilson, C. C., Martin, D. M., Kasamon, Y. L., Rowles, J., Ma, D. I., Slingluff, C. L. Jr., Wagner, S. N., van der Bruggen, P., Baar, J., Lotze, M. T., Storkus, W. J. (1998). Autologous Human Monocyte-Derived Dendritic Cells Genetically Modified to Express Melanoma Antigens Elicit Primary Cytotoxic T Cell Responses In Vitro: Enhancement by Cotransfection of Genes Encoding the Th1-Biasing Cytokines IL-12 and IFN-{alpha}. J. Immunol. 160: 1139-1147 [Abstract] [Full Text]
Wang, R.-F., Johnston, S. L., Southwood, S., Sette, A., Rosenberg, S. A. (1998). Recognition of an Antigenic Peptide Derived from Tyrosinase-Related Protein-2 by CTL in the Context of HLA-A31 and -A33. J. Immunol. 160: 890-897 [Abstract] [Full Text]
Osanto, S. (1997). Vaccine Trials for the Clinician: Prospects for Tumor Antigens. The Oncologist 2: 284-299 [Abstract] [Full Text]
Vierboom, M. P.M., Nijman, H. W., Offringa, R., Voort, E. I.H. v. d., Hall, T. v., Broek, L. v. d., Fleuren, G. J., Kenemans, P., Kast, W. M., Melief, C. J.M. (1997). Tumor Eradication by Wild-type p53-specific Cytotoxic T Lymphocytes. J. Exp. Med. 186: 695-704 [Abstract] [Full Text]
Reiter, Y., Di Carlo, A., Fugger, L., Engberg, J., Pastan, I. (1997). Peptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T cell receptor-like specificity. Proc. Natl. Acad. Sci. USA 94: 4631-4636 [Abstract] [Full Text]
Chen, Y.-T., Scanlan, M. J., Sahin, U., Tureci, O., Gure, A. O., Tsang, S., Williamson, B., Stockert, E., Pfreundschuh, M., Old, L. J. (1997). A testicular antigen aberrantly expressed in human cancers detected by autologous antibody�screening. Proc. Natl. Acad. Sci. USA 94: 1914-1918 [Abstract] [Full Text]
Dubey, P., Hendrickson, R. C., Meredith, S. C., Siegel, C. T., Shabanowitz, J., Skipper, J. C.A., Engelhard, V. H., Hunt, D. F., Schreiber, H. (1997). The Immunodominant Antigen of an Ultraviolet-induced Regressor Tumor Is Generated by a Somatic Point Mutation in the DEAD Box Helicase p68. J. Exp. Med. 185: 695-706 [Abstract] [Full Text]
Bloom, M. B., Perry-Lalley, D., Robbins, P. F., Li, Y., El-Gamil, M., Rosenberg, S. A., Yang, J. C. (1997). Identification of Tyrosinase-related Protein 2�as a Tumor Rejection Antigen for the B16 Melanoma. J. Exp. Med. 185: 453-460 [Abstract] [Full Text]
Wang, R.-F., Appella, E., Kawakami, Y., Kang, X., Rosenberg, S. A. (1996). Identification of TRP-2 as a Human Tumor Antigen Recognized by Cytotoxic T Lymphocytes. J. Exp. Med. 184: 2207-2216 [Abstract] [Full Text]
Luescher, I. F., Romero, P., Kuznetsov, D., Rimoldi, D., Coulie, P., Cerottini, J.-C., Jongeneel, C. V. (1996). HLA Photoaffinity Labeling Reveals Overlapping Binding of Homologous Melanoma-associated Gene Peptides by HLA-A1, HLA-A29, and HLA-B44. J. Biol. Chem. 271: 12463-12471 [Abstract] [Full Text]
Miconnet, I., Servis, C., Cerottini, J.-C., Romero, P., Levy, F. (2000). Amino Acid Identity and/or Position Determines the Proteasomal Cleavage of the HLA-A*0201-restricted Peptide Tumor Antigen MAGE-3271-279. J. Biol. Chem. 275: 26892-26897 [Abstract] [Full Text]